The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
2020 · Nature Reviews Endocrinology · 558 citations
https://doi.org/10.1038/s41574-020-0386-0
L
Leiluo Geng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
1.4K
Citations
10
h-index
10
i10-index
Leiluo Geng is an academic researcher from Chinese University of Hong Kong. The author has contributed to research in topics: Fibroblast Growth Factor Research & Kruppel-like factors research & Epigenetics and DNA Methylation. The author has an h-index of 10, co-authored 17 publications.
Papers by this author
worksFGF21–Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
2022 · Circulation · 212 citations
https://doi.org/10.1161/circulationaha.122.059631
Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues
2019 · Cell Reports · 179 citations
https://doi.org/10.1016/j.celrep.2019.02.014
Association of hemoglobin glycation index with the severity and mortality of cardiovascular-kidney-metabolic syndrome: a population-based cohort study
2025 · Cardiovascular Diabetology – Endocrinology Reports · 0 citations
https://doi.org/10.1186/s40842-025-00262-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat